Cargando…
Effects of Ninjin'yoeito on Human CYP3A and Mouse CYP3A Activity
Ninjin'yoeito (NYT) is widely used clinically for the management of patients with frailty and other multiple symptoms. NYT is often administered with other drugs; however, little information is available on its drug interactions. Previous studies using human liver microsomes have reported that...
Autores principales: | Kaneda, Marisa, Oyama, Manami, Yoshimi, Takashi, Michihara, Seiwa, Han, Li-Kun, Fujita, Nina, Takahashi, Ryuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412298/ https://www.ncbi.nlm.nih.gov/pubmed/37565226 http://dx.doi.org/10.1155/2023/8657478 |
Ejemplares similares
-
Ninjin'yoeito Alleviates Neuropathic Pain Induced by Chronic Constriction Injury in Rats
por: Takemoto, Risa, et al.
Publicado: (2021) -
Ninjin’yoeito suppressed the onset of arthritis, pain, and muscle atrophy in rheumatoid arthritis model mice
por: Suginohara, Takeshi, et al.
Publicado: (2022) -
Ninjin’yoeito ameliorated PPE-induced pulmonary emphysema and anxiety/depressive-like behavior in aged C57BL/6J mice
por: Shimoyama, Taiki, et al.
Publicado: (2022) -
Impact of Ninjin’yoeito on frailty and short life in klotho-hypomorphic (kl/kl) mice
por: Amitani, Haruka, et al.
Publicado: (2022) -
A Clinical Study of Ninjin'yoeito With Regard to Frailty
por: Sakisaka, Naoya, et al.
Publicado: (2018)